31.07.2015 Views

Advances in the stereoselective synthesis of antifungal agents and ...

Advances in the stereoselective synthesis of antifungal agents and ...

Advances in the stereoselective synthesis of antifungal agents and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 1 13The four stereoisomers <strong>of</strong> Ketoconazole 4a were evaluated for <strong>the</strong>ireffectiveness as <strong>in</strong>hibitors <strong>of</strong> <strong>the</strong> cytochrome P450 <strong>in</strong>volved <strong>in</strong>:(a) cholesterol biosyn<strong>the</strong>sis <strong>and</strong> degradation (lanosterol 14-α−demethylase <strong>and</strong> cholesterol 7-α−hydroxylase); (b) steroid hormonebiosyn<strong>the</strong>sis (cholesterol side cha<strong>in</strong> cleavage, progesterone 17α,20-lyase,deoxycorticosterone 11-β hydroxylase <strong>and</strong> aromatase) <strong>and</strong> (c) xenobiotictransformation (lauric acid hydroxylation <strong>and</strong> progesterone2α −, 6 β −, 15 α −, 16 α −, 21 hydroxylation) 36 .It was shown that <strong>the</strong> cis-isomers are more potent <strong>in</strong>hibitors <strong>of</strong>mammalian lanosterol 14-α−demethylase than <strong>the</strong> diastereomeric transisomers.The cis-(2S,4R) isomer is three times more active than itsantipode 36 .The most important analogues <strong>of</strong> Ketoconazole 4a are Terconazole4b, cis- 1,4,2- (2,4-dichlorophenyl) -2- (1-ylmethyl) -1,3 -dioxolan - 4-ylmetoxyphenyl -4- (methylethyl) piperaz<strong>in</strong>e, a triazole ketal syn<strong>the</strong>sized byJanssen Pharmaceuticals. 39In this case <strong>the</strong> heterocyclic moiety is a 1,2,4 triazole <strong>in</strong>stead <strong>of</strong> <strong>the</strong>imidazole, <strong>and</strong> conta<strong>in</strong>s a t-butyl group <strong>in</strong>stead <strong>of</strong> an acetate group <strong>in</strong>position 4 <strong>of</strong> <strong>the</strong> piperaz<strong>in</strong>e.In 1995, Menar<strong>in</strong>i reported <strong>the</strong> first <strong>stereoselective</strong> syn<strong>the</strong>sis <strong>of</strong> (+)-or(-)-Terconazole 4b.The syn<strong>the</strong>sis <strong>of</strong> both enantiomers <strong>of</strong> Terconazole employed asstart<strong>in</strong>g material (2R,4R)-(+)-<strong>and</strong> (2S,4S)-(-)-bromobenzoate 4d (Fig. 1.9)which have been also used as advanced chiral <strong>in</strong>termediates for <strong>the</strong>syn<strong>the</strong>sis <strong>of</strong> both enantiomers <strong>of</strong> ketoconazole 40 . Ano<strong>the</strong>r syn<strong>the</strong>sis <strong>of</strong> <strong>the</strong>analogues <strong>of</strong> Ketoconazole 4c has been reported <strong>in</strong> 1994 41 .Terconazole 4b has also been shown to be highly effective <strong>in</strong> vivo for<strong>the</strong> topical treatment <strong>of</strong> various experimental models <strong>of</strong> dermatomycosis<strong>and</strong> c<strong>and</strong>idiasis. It also shows some oral activity aga<strong>in</strong>st experimentally<strong>in</strong>duced superficial mycoses 42 .1.2.2.2 Miconazole <strong>and</strong> its analogues 5a-d.Miconazole 5a <strong>and</strong> its analogues 5b-d are shown <strong>in</strong> Fig 1.11.Miconazole 1 - [2,4 - dichloro -β- (2,4-dichloro-benzyloxy) phenyl]imidazole nitrate 5a is a phenylethyl imidazole derivative syn<strong>the</strong>sized byJanssen Pharmaceuticals <strong>in</strong> 1969 43 .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!